Published in J Clin Endocrinol Metab on October 21, 2009
Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth. J Pediatr (2012) 1.57
Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab (2011) 1.49
Pre-diabetes in overweight youth and early atherogenic risk. Metabolism (2014) 0.81
Anthropometric measurements for the prediction of the metabolic syndrome: a cross-sectional study on adolescents and young adults from southern india. Heart Asia (2011) 0.81
Effects of wheat and oat-based whole grain foods on serum lipoprotein size and distribution in overweight middle aged people: a randomised controlled trial. PLoS One (2013) 0.75
Development of waist circumference percentiles for Japanese children and an examination of their screening utility for childhood metabolic syndrome: a population-based cross-sectional study. BMC Public Health (2015) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr (2004) 7.08
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation (1997) 4.81
Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation (2000) 3.78
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord (2000) 3.65
The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr (2001) 3.34
Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol (1996) 3.18
Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab (2003) 3.01
Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr (1999) 2.91
Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr (2006) 2.46
Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes (2002) 2.45
Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem (1992) 2.36
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol (2007) 2.29
Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference. BMJ (2003) 2.21
Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.95
Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res (2001) 1.89
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J (1987) 1.88
Waist circumference percentiles for 7- to 15-year-old Australian children. Acta Paediatr (2005) 1.75
Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr (2006) 1.62
Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care (2007) 1.62
Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med (2005) 1.54
In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care (2009) 1.46
The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care (1996) 1.43
Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care (2006) 1.41
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes (2008) 1.41
Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care (2007) 1.30
Relation of body fat patterning to lipid and lipoprotein concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr (1989) 1.18
Postprandial triglyceride response in visceral obesity in men. Diabetes (1998) 1.12
Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study. Pediatrics (2002) 1.11
Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord (2002) 0.99
Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care (2001) 0.98
Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: the Bogalusa Heart Study. Am J Clin Nutr (2002) 0.98
Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism (1999) 0.97
LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow. Curr Med Res Opin (1996) 0.94
Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes (2004) 0.94
Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord (1998) 0.89
Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand J Clin Lab Invest (2005) 0.87
Low-density lipoprotein subclasses in children under 10 years of age. J Paediatr Child Health (2001) 0.85
Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab (2003) 3.01
Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care (2004) 2.60
Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr (2006) 2.46
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Childhood obesity and type 2 diabetes mellitus. Pediatrics (2005) 2.08
Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care (2003) 2.01
Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics (2009) 1.87
Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res (2006) 1.81
Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr (2008) 1.78
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab (2003) 1.65
Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr (2006) 1.62
Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth. J Pediatr (2012) 1.57
Race and gender differences in the relationships between anthropometrics and abdominal fat in youth. Obesity (Silver Spring) (2008) 1.56
Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care (2006) 1.52
In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care (2008) 1.52
Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care (2003) 1.52
Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab (2006) 1.52
Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab (2011) 1.49
In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care (2009) 1.46
Insulin resistance of puberty in African-American children: lack of a compensatory increase in insulin secretion. Pediatr Diabetes (2002) 1.45
Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care (2008) 1.42
Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care (2006) 1.41
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. J Clin Endocrinol Metab (2010) 1.34
Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care (2012) 1.27
Relationships among obstructive sleep apnea, anthropometric measures, and neurocognitive functioning in adolescents with severe obesity. J Pediatr (2011) 1.22
From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care (2010) 1.21
Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes (2011) 1.18
Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care (2011) 1.11
Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab (2005) 1.09
Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance. Int J Pediatr Obes (2010) 1.06
Comparison of maximal oxygen consumption between obese black and white adolescents. Pediatr Res (2005) 1.05
Measurement site of visceral adipose tissue and prediction of metabolic syndrome in youth. Pediatr Diabetes (2010) 1.01
Prediction equations for resting energy expenditure in overweight and normal-weight black and white children. Am J Clin Nutr (2004) 0.98
Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab (2012) 0.97
Progressive deterioration of β-cell function in obese youth with type 2 diabetes. Pediatr Diabetes (2012) 0.96
25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care (2013) 0.96
Prevention and treatment of type 2 diabetes in youth. Horm Res (2006) 0.94
Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study. J Pediatr Psychol (2008) 0.93
Comparison of maximal oxygen consumption between black and white prepubertal and pubertal children. Pediatr Res (2004) 0.93
Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring) (2006) 0.92
Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes (2006) 0.91
25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth. Diabetes Care (2012) 0.90
Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes (2005) 0.90
Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents. Diabetes Care (2008) 0.89
HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care (2012) 0.89
Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome. J Obes (2012) 0.89
Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents. Pediatr Diabetes (2013) 0.87
β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast. Diabetes (2013) 0.83
Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab (2007) 0.83
Fat oxidation in black and white youth: a metabolic phenotype potentially predisposing black girls to obesity. J Clin Endocrinol Metab (2008) 0.80
β-Cell lipotoxicity after an overnight intravenous lipid challenge and free fatty acid elevation in African American versus American white overweight/obese adolescents. J Clin Endocrinol Metab (2013) 0.79
Differences in stimulated androgen levels in black and white obese adolescent females. J Pediatr Adolesc Gynecol (2011) 0.76
Gestational Weight Gain and Offspring Longitudinal Growth in Early Life. Ann Nutr Metab (2015) 0.75
Obesity is not linked to increased whole-body mast cell burden in children. J Allergy Clin Immunol (2012) 0.75
Type 2 diabetes in children and adolescents: a review for the primary care provider. Pediatr Ann (2006) 0.75
Short-term pharmacologically induced growth study of ontogenetic allometry of oxygen uptake in children. Ann Hum Biol (2006) 0.75
Eating disorders. A meter tells the real story. Diabetes Forecast (2002) 0.75